Application Progress in the Surgical Treatment of Differentiated Thyroid Cancer
DOI:
https://doi.org/10.53469/jcmp.2024.06(09).14Keywords:
Differentiated thyroid cancer, Surgical treatment, Application progressAbstract
Differentiated thyroid cancer accounts for more than 90% of thyroid cancer, including follicular and papillary carcinoma, and surgery is the main way to treat the disease. With the increasing incidence of thyroid cancer in recent years, the progress of its main treatment methods has attracted people's attention. In order to achieve good treatment results and promote the prognosis of patients, they should accurately evaluate their actual condition before surgery, and then choose the appropriate surgical method. This article mainly reviews the technology and application effect of DTC surgical treatment, in order to provide more basis and reference for the formulation of surgical treatment plans for DTC patients.
References
Zheng RS, Zhang SW, Zeng HM, et al. Cancer incidence and mortality in China, 2016[J]. J Nat Cancer Cent, 2022, 2022(1); 5:38.
Liu Wanchun. Progress of Clinical Research on Surgical Treatment of Differentiated Thyroid Cancer[J]. Journal of Practical Medical Techniques, 2022, 29(1):104-106.
CRACOLICI V. No longer well-differentiated: diagnostic criteria and clinical importance of poorly differentiated/high-grade thyroid carcinoma[J]. Surg Pathol Clin, 2023, 16(1): 45-56.
TIAN Wen, XI Hong-qing. Current status and future perspectives in differentiated thyroid cancer[J]. Chinese Journal of Practical Surgery, 2020, 40(1): 78-82.
LIU Ming, GENG Jianhua, LIANG Ying. Research progress of 131I concentration in the air in the 131I thyroid carcinoma treatment site[J]. Chinese Journal of Radiological Health, 2019, 28(6): 734-736.
Yin, Jingxia, Cui, Long, Pu, Danlan, et al. 2023 Interpretation of the Guidelines for the Diagnosis and Management of Thyroid Nodules and Differentiated Thyroid Cancer (Second Edition) [J]. Journal of Modern Medicine & Health, 2023, 39(8):1261-1266.
QIN Tian-jiao, LI Ming-hui, GAO Chen-hui. High Frequency Ultrasound, Ultrasound-Guided Fine-needle Aspiration Biopsy (US-FNAB) in the Diagnosis of Papillary Thyroid Carcinoma (PTMC) [J]. Journal of Rare and Uncommon Diseases, 2023, 30(6): 22-24.
National Health Commission of the People’s Republic of China. Thyroid cancer diagnosis and treatment norms (2018 edition) [J]. Chinese Literature of General Surgery (Electronic Edition), 2019, 13(1): 1-15.
Ye Ziheng, Guo Minggao. Advances in the application of molecular testing in preoperative diagnosis of differentiated thyroid cancer[J]. Chinese Journal of Otorhinolaryngology Head and Neck Surgery, 2020, 55(6): 641-644.
Wang Xinxia, Ma Tengchuang, Cui Yali. Research progress in accurate targeted therapy for radioiodine refractory differentiated thyroid cancer[J]. International Journal of Radiation Medicine and Nuclear Medicine, 2019, 43(6): 569-575.
CINZIA NP, HANNA R, CAROLE G, et al. Accidental parathyroidectomy during total thyroidectomy and hypoparathyroidism in a large series of 766 patients: incidence and consequences in a referral center[J]. Langenbeck’s Archives of Surgery, 2023, 408(1): 393.
KANG Wenyu, WANG Xiang. Unilateral total lobectomy plus isthmectomy versus bilateral total lobectomy in treatment of papillary thyroid microcarcinoma [J]. Journal of Clinical Medicine in Practice, 2019, 23(1): 71-74, 80.
TAN Yuewen, YU Zhaoshi, LIU Huiyi. The Effect of Total Thyroidectomy in the Treatment of Differentiated Thyroid Cancer [J]. Medical Innovation of China, 2023, 20(27): 23-26.
ZHANG Wanyong, ZHAO Xiaoli. Clinical Efficacy of Total Thyroidectomy in the Treatment of Differentiated Thyroid Cancer[J]. Clinical Research, 2023, 31(8): 98-100, 104.
GU Yanzhong, YANG Rui, WU Hongji, et al. Progress in diagnosis and treatment of lateral cervical lymph node dissection in medullary thyroid carcinoma[J], Chinese Journal of Bases and Clinics In General Surgery, 2023, 30(10): 1273-1280.
WANG Junqi. Clinical and therapeutic perspectives on differentiated thyroid cancer[J]. The Journal of Practical Medicine, 2019, 35 (20): 3258-3263.
ZHANG Danfeng, LIU Xuegong. The clinical value of serologic markers in the management of the patients with differentiated thyroid carcinoma[J]. Chinese Journal of Surgical Oncology, 2019, 11(5): 79-82.
YU Weiming, DAI Wenjie. Advances in Surgical Diagnosis and Treatment of Primary Hyperparathyroidism with Differentiated Thyroid Cancer [J]. Medical Recapitulate, 2019, 25 (11): 2154-2157, 2163.
Zheng Qianqian, Yang Weiwei, Wang Huijuan, et al. Progress in the diagnosis and treatment of differentiated thyroid cancer[J]. Chinese Journal of General Surgery, 2019, 34 (3): 273-276.
Wang Y, Chen W, Shan X. Advances in the treatment of patients with differentiated thyroid cancer[J]. Medical Equipment, 2018, 31 (18): 203-204.
LI Chunxu, DAI Wenjie. Research Progress in Diagnosis and Treatment of Radioiodine Refractory Differentiated Thyroid Carcinoma[J]. Medical Recapitulate, 2018, 24(12): 80-84.
Zhang Lilin, Zhao Liufang, Li Xiaojiang. Progress in diagnosis and treatment of recurrent or metastatic differentiated thyriod cancer[J]. International Journal of Otolaryngology-Head and Neck Surgery, 2018, 42 (3): 149-153.
ZHU Hui, HOU Xian-cun, SHEN Wei, et al. Clinical Evaluation of Levothyroxine Sodium Tablets Combined with Thyroid Tablets for TSH Suppression Therapy after Thyroid Cancer Surgery[J]. Progress in Modern Biomedicine, 2023, 23(6): 1136-1140.
Xin Wang, Feng Zhao, Shuang Yan. Effect of TSH inhibition therapy on bone metabolism, CD44v6, and sIL-2R levels in patients with differentiated thyroid carcinoma[J]. China Journal of Modern Medicine, 2022, 32(23): 34-38.
CHENG Ruo-chuan. Current status and thinking of postoperative thyroid stimulating hormone suppression therapy for differentiated thyroid cancer[J]. Chinese Journal of Practical Surgery, 2023, 43(4): 391-396.
CAMPENNI A, RUGGERI RM, Garo ML, et al. Comparison of 1.1 GBq and 2.2 GBq activities in patients with low-risk differentiated thyroid cancer requiring postoperative 131I administration: a real life study[J]. Cancers (Basel), 2023, 15(9): 2416.
XU Weihong, MEI Feng, LI Qiang. Efficacy of transoral laparoscopic thyroidectomy by vestibular approach combined with 131Ⅰtreatment in differentiated thyroid carcinoma and analysis of short-and medium-term prognoses [J]. Chinese Journal of Medical Physics, 2022, 39(12): 1563-1568.
FENG Zhiping, CHEN Fukun, YANG Chuanzhou, et al. miR-143-3p targeted KRAS to block PI3K/Akt signaling pathway and inhibit proliferation, invasion and migration of differentiated thyroid carcinoma cells[J]. Journal of Modern Oncology, 2021, 29(14): 2387-2393.
BIAN Fang, LI Ning, LI Qi, Peptide P11 inhibits the proliferation and invasion of differentiated thyroid cancer cells by up-regulating the expression of miR-126[J]. Modern Medical Journal, 2021, 49(8): 833-840.
Feng, K.X. Role and mechanism of SLC27A2/FATP2 in the proliferation and migration of differentiated thyroid cancer [D]. Zhengzhou: Zhengzhou University, 2021.
WANG Ning, LIU Jinbiao. The Mechanism of Action of Lenvatinib in the Regulation of VEGFR/PI3K/AKT in the Treatment of Advanced Thyroid Cancer[J], The Practical Journal of Cancer, 2021, 36(3): 415-418, 422.
Thyroid Surgery Committee of Chinese Physicians Association, Chinese Society of Research Hospitals, Thyroid Surgery Group of Thyroid Disease Committee, and Thyroid and Parathyroid Experts of General Surgery Committee of Chinese Society of Integrative Medicine. Chinese expert consensus on surgical treatment of locally advanced thyroid cancer (2020 edition) [J]. Chinese Journal of Practical Surgery, 2020, 40(4): 369-376.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Yuanhao Su, Yi Jin
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
